日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells.

自分泌胰岛素样生长因子 1 和干细胞因子(而非白细胞介素 6)支持人类骨髓瘤细胞的自我更新

Chiron D, Maïga S, Surget S, Descamps G, Gomez-Bougie P, Traore S, Robillard N, Moreau P, Le Gouill S, Bataille R, Amiot M, Pellat-Deceunynck C

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

睫状神经营养因子、白细胞介素 11、白血病抑制因子和抑瘤素 M 是利用白细胞介素 6 信号转导蛋白 gp130 的人类骨髓瘤细胞系的生长因子。

Zhang, X G; Gu, J J; Lu, Z Y; Yasukawa, K; Yancopoulos, G D; Turner, K; Shoyab, M; Taga, T; Kishimoto, T; Bataille, R

Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6

注射抗IL-6的鼠单克隆抗体后,人抗鼠抗体反应

Legouffe, E; Liautard, J; Gaillard, J P; Rossi, J F; Wijdenes, J; Bataille, R; Klein, B; Brochier, J

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

新的成骨细胞和破骨细胞的募集是人类多发性骨髓瘤发病机制中最早期的关键事件。

Bataille, R; Chappard, D; Marcelli, C; Dessauw, P; Baldet, P; Sany, J; Alexandre, C

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

血清中白细胞介素 6(一种强效的骨髓瘤细胞生长因子)的水平可反映浆细胞疾病的严重程度。

Bataille, R; Jourdan, M; Zhang, X G; Klein, B